383 related articles for article (PubMed ID: 19783184)
1. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
3. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
[TBL] [Abstract][Full Text] [Related]
4. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
[TBL] [Abstract][Full Text] [Related]
5. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
7. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
[TBL] [Abstract][Full Text] [Related]
8. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
10. Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart.
Ogletree ML; Sweet WE; Talerico C; Klecka ME; Young JB; Smedira NG; Starling RC; Moravec CS
J Heart Lung Transplant; 2010 May; 29(5):554-61. PubMed ID: 20044278
[TBL] [Abstract][Full Text] [Related]
11. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices.
Thohan V; Stetson SJ; Nagueh SF; Rivas-Gotz C; Koerner MM; Lafuente JA; Loebe M; Noon GP; Torre-Amione G
J Heart Lung Transplant; 2005 May; 24(5):566-75. PubMed ID: 15896754
[TBL] [Abstract][Full Text] [Related]
12. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
Klotz S; Naka Y; Oz MC; Burkhoff D
J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
[TBL] [Abstract][Full Text] [Related]
13. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
[TBL] [Abstract][Full Text] [Related]
14. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
[TBL] [Abstract][Full Text] [Related]
15. Partial left ventricular unloading reverses contractile dysfunction and helps recover gene expressions in failing rat hearts.
Wang J; Marui A; Ikeda T; Komeda M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):27-31. PubMed ID: 18006556
[TBL] [Abstract][Full Text] [Related]
16. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.
Xydas S; Rosen RS; Ng C; Mercando M; Cohen J; DiTullio M; Magnano A; Marboe CC; Mancini DM; Naka Y; Oz MC; Maybaum S
J Heart Lung Transplant; 2006 Jan; 25(1):7-15. PubMed ID: 16399524
[TBL] [Abstract][Full Text] [Related]
17. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
Klotz S; Jan Danser AH; Burkhoff D
Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
Jahanyar J; Youker KA; Torre-Amione G; Koerner MM; Bruckner B; Noon GP; Loebe M
J Heart Lung Transplant; 2008 Jul; 27(7):701-9. PubMed ID: 18582797
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of the human failing heart after left ventricular assist device support.
de Weger RA; Schipper ME; Siera-de Koning E; van der Weide P; van Oosterhout MF; Quadir R; Steenbergen-Nakken H; Lahpor JR; de Jonge N; Bovenschen N
J Heart Lung Transplant; 2011 May; 30(5):497-506. PubMed ID: 21211997
[TBL] [Abstract][Full Text] [Related]
20. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
